Epstein-Barr Virus Viral Capsid Antigen IgA Antibody Test
The Epstein-Barr Virus (EBV) Viral Capsid Antigen (VCA) IgA Antibody Test detects IgA antibodies that may indicate recent or reactivated EBV infection. Elevated IgA levels are often associated with nasopharyngeal carcinoma and other EBV-related conditions. Doctors order this test for patients with persistent sore throat, swollen lymph nodes, or suspected EBV reactivation. Results provide valuable insight for diagnosis, cancer risk assessment, and ongoing monitoring.
- $197.95
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Epstein Barr Viral Capsid Antigen Iga Ab IFA
Epstein Barr Viral Capsid
The Epstein-Barr Virus Viral Capsid Antigen IgA Antibody Test test contains 1 test with 1 biomarker .
Epstein-Barr Viral Capsid Antigen (VCA) Antibody (IgA)
Clinical Significance
Epstein-Barr Viral Capsid Antigen (VCA) Antibody (IgA) - VCA IgA titers ≥1:80 are suggestive of chronic or reactivated EBV infection, whereas titer of 1:10, 1:20, or 1:40 typically indicate past infection.
Reference Range(s)
<1:10
Interpretive Criteria
- <1:10Antibody not detected
- 1:10-1:40Past infection
- ≥1:80Chronic/Reactivated infection